Skip to content

Transcranial Magnetic Stimulation in Patients With Disorders of Consciousness

Effects of Repetitive Transcranial Magnetic Stimulation on the Disorders of Consciousness

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03385278
Enrollment
10
Registered
2017-12-28
Start date
2015-04-30
Completion date
2018-02-28
Last updated
2017-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorder of Consciousness

Keywords

TMS;DOC

Brief summary

Transcranial magnetic stimulation involves the use of alternating magnetic fields to stimulate neurons in the brain.To date, several studies have focused on the use of TMS in patients with impaired consciousness.However,its therapeutic effects have been variously documented.So,in this study ,investigators explore the effects of rTMS with cross-over design.

Detailed description

Background:Repetitive transcranial magnetic stimulation (rTMS) was supposed as an experimental approach to disorders of consciousness treatment. Its therapeutic effects have been variously documented. Objective: The study aimed to investigate the reactivity of electroencephalography (EEG) and the clinical response of patients with disorders of consciousness and explore the neuromodulatory effects of high-frequency rTMS in DOC. Method:In this randomised,sham-controlled study,real or sham 20 Hz rTMS were applied to the left primary motor cortex (M1) of participants with disorders of consciousness for 5 consecutive days . Evaluations were blindly performed at baseline, immediately after the end of the 5-days treatment and 1 week later with the JFK Coma Recovery Scale-Revised (CRS-R) scale and EEG. Hypothesis:Real rTMS can be an effective awakening method.

Interventions

OTHERrTMS

20HZ Repetitive Transcranial Magnetic Stimulation

Sponsors

First Affiliated Hospital of Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Intervention model description

This study was designed and performed as a randomized, controlled cross-over trial. All patients were randomly received active 20-Hz rTMS and sham stimulation for 5 consecutive days, in separate sessions spaced one week.

Eligibility

Sex/Gender
ALL
Age
14 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients ages 14 to 65 years old; 2. no centrally acting drugs; 3. no neuromuscular function blockers and no sedation within the prior 24 hours; 4.periods of eye opening (indicating preserved sleep-wake cycles); 5.DOC patients, including vegetative state and minimally consciousness state.

Exclusion criteria

1. History with nervous or spirit disorders, or some other serious diseases such as cardiac or pulmonary problems; 2. with a contraindication for rTMS

Design outcomes

Primary

MeasureTime frameDescription
the JFK Coma Recovery Scale-Revised (CRS-R) scaleat baseline (T0), immediately after the end of the 5-day treatment (T1), 1 week later (T2).Investigators observed the changes from baseline to the end of stimulation.The CRS-R is a tool used to characterise the level of consciousness.The CRS-R is a tool used to characterize the level of consciousness and to monitor neurobehavioural recovery in DOC. The scale consists of 23 hierarchically arranged items that comprise six subscales addressing the auditory, visual, motor, oromotor/verbal, communication and arousal processes. The lowest item on each subscale represents reflexive activity whereas the highest item represents cognitively mediated behaviors.

Secondary

MeasureTime frameDescription
EEG data ( electrophysiological parameters)at baseline (T0), immediately after the end of the 5-day treatment (T1), 1 week later (T2)delta (1-4 Hz), theta (4-8 Hz), alpha (8-12 Hz) and beta (12-30 Hz).an increase of delta and theta activity usually reflects encephalopathy and/or structural lesions, interpreted as poor outcome predictor of DOC .The power of α and β is related to the chance of recovery.

Countries

China

Contacts

Primary ContactMin Wu
18826401709@163.com
Backup ContactBenyan Luo
luobenyan@zju.edu.cn

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026